Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are ...

Diabetes and weight loss injectables Ozempic and Wegovy, the brand names for semaglutide, get dramatic results because they slow the movement of food through the digestive system. That’s how the drugs ...

A new study suggests people taking popular injected medications for weight loss, including Wegovy, Ozempic, Saxenda and Victoza, may be at higher risk for serious digestive problems such as stomach ...

The meteoric rise of GLP-1 receptor agonists like Ozempic and Wegovy has transformed the landscape of diabetes and obesity ...

A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments. The proof-of-concept study introduced a ...

The digestive system’s rhythms are controlled by body clock genes, as well as lesser-known regulators called noncanonical clock regulators. Researchers at Baylor College of Medicine aimed to ...

GLP-1 drugs carry a wide range of risks, from common symptoms such as nausea and vomiting to severe complications, including ...

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael ...